The Ninth Circuit Court of Appeals blocked Arizona’s medication abortion restriction Tuesday, calling the law an “undue burden” on women that lacked any basis in medical evidence.
The rationale for the Arizona law was to “protect women from the dangerous and potentially deadly off-label use of abortion-inducing drugs, such as, for example, mifepristone.” But the the Ninth Circuit’s three-judge panel, in an opinion authored Tuesday by Judge William A. Fletcher, examined the record and the opinions of physicians and found that “Arizona introduced no evidence that the law advanced in any way Arizona’s interest in women’s health.”
The newer, off-label regimen offers women more choices: It makes the pill available two more weeks, lowers the dosage for potentially fewer side effects and less out-of-pocket expense, and means one fewer visit to the clinic. It’s also the one preferred by major medical organizations.
“Consistent with common terminology,” the court said, “we call this off-label regimen the ‘evidence-based’ regimen.”









